Trademarkia Logo

Australia

AU$
DEURA9
Accepted: In opposition period

Last updated on 17 Sept 2024

Owner Info

Lennham Pharmaceuticals, Inc.

53 Main Street, Suite 206

Concord MA 01742, UNITED STATES OF AMERICA

Serial Number

2463332 filed on 14 Mar 2024

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

DEURA9

Classification Information


Class [001]
Chemical compound, namely, deuterated caffeine for use as an ingredient in food and beverages; deuterated caffeine ingredient used in the manufacture Read More

Mark Details


Serial Number

2463332

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Sept 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
17th Sept 2024International Registration in Australia Protected correspondence sent
16th Sept 2024IP Right Registration Published
16th Sept 2024Status change to Registered/Protected
9th Jul 2024Application Accepted correspondence sent
8th Jul 2024IP Right has been Examined
8th Jul 2024IP Right Acceptance Published
8th Jul 2024Status change to Accepted
4th Jul 2024Examination expedited
4th Jul 2024Awaiting examination
4th Jul 2024IP Right Filed Published